Get startedLog in
    Picture of Annexon logo

    ANNX — Annexon News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapSucker Stock
    All News

    Brief: Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025

    Picture of Annexon logoAnnexon
    18/06/2025 22:48
    June 18 (Reuters) - Annexon Inc ANNX.O:

ANNEXON INC - ENROLLMENT OF PHASE 3 ARCHER II TRIAL EXPECTED TO BE COMPLETED IN Q3 2025, WITH TOPLINE DATA EXPECTED IN SECOND HALF OF 2026

Source text: ID:nGNX5QZfJf

Further company coverage: ANNX.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Annexon

    See all news